{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T20:43:12Z","timestamp":1703018592349},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sugammadex reverses neuromuscular blockade induced by steroidal relaxants. We compared the recovery for neuromuscular blockade reversal with sugammadex in children aged 1\u201312\u2009years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From August 2019 to August 2020, patients who received 2.0\u2009mg\u00b7kg<jats:sup>\u2212\u20091<\/jats:sup> sugammadex for neuromuscular blockade reversal after surgery were recruited. The primary outcome was the time for the train-of-four ratio (TOFR) to recover to 0.9; secondary outcomes included the incidence of the TOFR &lt;\u20090.9, extubation time, length of stay at the post-anesthesia care unit, and adverse events. Hemodynamic parameters before and 5\u2009min after sugammadex administration and vital signs in the recovery room were also recorded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eighty-six children were recruited (1 to &lt;\u20093\u2009years, <jats:italic>n<\/jats:italic>\u2009=\u200923; 3 to &lt;\u20095\u2009years, <jats:italic>n<\/jats:italic>\u2009=\u200933; 5 to \u226412\u2009years, <jats:italic>n<\/jats:italic>\u2009=\u200930). Intergroup differences in the recovery of the TOFR to 0.9 were not statistically significant (F\u2009=\u20090.691, <jats:italic>p<\/jats:italic>\u2009=\u20090.504). Recurrence of the TOFR &lt;\u20090.9 was not observed in any group. Five minutes after sugammadex administration, the heart rates of patients aged 3 to &lt;\u20095 and 5 to \u226412\u2009years were significantly lower than those at baseline (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Extubation time was similar in patients aged 1 to \u226412\u2009years. Length of stay and end-tidal capnography at the post-anesthesia care unit as well as adverse events did not differ significantly.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A moderate (TOF count two) rocuronium-induced neuromuscular blockade can be effectively and similarly reversed with sugammadex 2\u2009mg\u00b7kg<jats:sup>\u2212\u20091<\/jats:sup> in Chinese children aged 1\u201312\u2009years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Chinese Clinical Trial Registry: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.chictr.org.cn\/showproj.aspx?proj=39576\">ChiCTR1900023715<\/jats:ext-link> (June 8, 2019).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12871-021-01465-9","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T04:50:42Z","timestamp":1634619042000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of age on sugammadex reversal of neuromuscular blockade induced by rocuronium in Chinese children: a prospective pilot trial"],"prefix":"10.1186","volume":"21","author":[{"given":"Ruidong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengde","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jijian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"1465_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1460-9592.2010.03335.x","volume":"20","author":"OA Meretoja","year":"2010","unstructured":"Meretoja OA. Neuromuscular block and current treatment strategies for its reversal in children. Paediatr Anaesth. 2010;20:591\u2013604.","journal-title":"Paediatr Anaesth"},{"key":"1465_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1213\/ANE.0b013e3181da832d","volume":"111","author":"GS Murphy","year":"2010","unstructured":"Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg. 2010;111:120\u20138.","journal-title":"Anesth Analg"},{"key":"1465_CR3","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/aas.12868","volume":"61","author":"AS Ammar","year":"2017","unstructured":"Ammar AS, Mahmoud KM, Kasemy ZA. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children. Acta Anaesthesiol Scand. 2017;61:374\u201380.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1465_CR4","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1097\/00000542-200305000-00004","volume":"98","author":"B Debaene","year":"2003","unstructured":"Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003;98:1042\u20138.","journal-title":"Anesthesiology."},{"key":"1465_CR5","first-page":"410248","volume":"2015","author":"T Ledowski","year":"2015","unstructured":"Ledowski T, O\u2019Dea B, Meyerkort L, Hegarty M, von Ungern-Sternberg BS. Postoperative residual neuromuscular paralysis at an Australian tertiary children\u2019s hospital. Anesthesiol Res Pract. 2015;2015:410248.","journal-title":"Anesthesiol Res Pract"},{"key":"1465_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2165\/00002512-200825100-00006","volume":"25","author":"K Johnell","year":"2008","unstructured":"Johnell K, Fastbom J. Concurrent use of anticholinergic drugs and cholinesterase inhibitors: register-based study of over 700,000 elderly patients. Drugs Aging. 2008;25:871\u20137.","journal-title":"Drugs Aging"},{"key":"1465_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12871-017-0429-9","volume":"17","author":"H Iwasaki","year":"2017","unstructured":"Iwasaki H, Renew JR, Kunisawa T, Brull SJ. Preparing for the unexpected: special considerations and complications after sugammadex administration. BMC Anesthesiol. 2017;17:140.","journal-title":"BMC Anesthesiol"},{"key":"1465_CR8","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1021\/jm011107f","volume":"45","author":"JM Adam","year":"2002","unstructured":"Adam JM, Bennett DJ, Bom A, Clark JK, Feilden H, Hutchinson EJ, et al. Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships. J Med Chem. 2002;45:1806\u201316.","journal-title":"J Med Chem"},{"key":"1465_CR9","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1248\/bpb.b19-00044","volume":"42","author":"M Matsui","year":"2019","unstructured":"Matsui M, Konishi J, Suzuki T, Sekijima C, Miyazawa N, Yamamoto S. Reversibility of Rocuronium-induced deep neuromuscular block with Sugammadex in infants and children-a randomized study. Biol Pharm Bull. 2019;42:1637\u201340.","journal-title":"Biol Pharm Bull"},{"key":"1465_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/pan.13050","volume":"27","author":"JD Tobias","year":"2017","unstructured":"Tobias JD. Current evidence for the use of sugammadex in children. Paediatr Anaesth. 2017;27:118\u201325.","journal-title":"Paediatr Anaesth"},{"key":"1465_CR11","doi-asserted-by":"publisher","first-page":"e4678","DOI":"10.1097\/MD.0000000000004678","volume":"95","author":"YJ Won","year":"2016","unstructured":"Won YJ, Lim BG, Lee DK, Kim H, Kong MH, Lee IO. Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95:e4678.","journal-title":"Medicine (Baltimore)"},{"key":"1465_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1440-1754.2007.01254.x","volume":"45","author":"M Yung","year":"2009","unstructured":"Yung M, Keeley S. Randomised controlled trial of intravenous maintenance fluids. J Paediatr Child Health. 2009;45:9\u201314.","journal-title":"J Paediatr Child Health"},{"key":"1465_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/ALN.0000000000002870","volume":"131","author":"TW Templeton","year":"2019","unstructured":"Templeton TW, Goenaga-D\u00edaz EJ, Downard MG, McLouth CJ, Smith TE, Templeton LB, et al. Assessment of common criteria for awake extubation in infants and young children. Anesthesiology. 2019;131:801\u20138.","journal-title":"Anesthesiology."},{"key":"1465_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/ALN.0b013e318194caaa","volume":"110","author":"B Plaud","year":"2009","unstructured":"Plaud B, Meretoja O, Hofmockel R, Raft J, Stoddart PA, van Kuijk JH, et al. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology. 2009;110:284\u201394.","journal-title":"Anesthesiology."},{"key":"1465_CR15","volume-title":"Sample size calculations in clinical research","author":"SC Chow","year":"2018","unstructured":"Chow SC, Shao J, Wang HS, Lokhnygina Y. Sample size calculations in clinical research. 3rd ed. Boca Raton: CRC Press; 2018.","edition":"3"},{"key":"1465_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/bja\/83.1.58","volume":"83","author":"DM Fisher","year":"1999","unstructured":"Fisher DM. Neuromuscular blocking agents in paediatric anaesthesia. Br J Anaesth. 1999;83:58\u201364.","journal-title":"Br J Anaesth"},{"key":"1465_CR17","doi-asserted-by":"publisher","first-page":"110180","DOI":"10.1016\/j.biopha.2020.110180","volume":"127","author":"L Xiaobing","year":"2020","unstructured":"Xiaobing L, Yan J, Wangping Z, Rufang Z, Jia L, Rong W. Effects of sugammadex on postoperative respiratory management in children with congenital heart disease: a randomized controlled study. Biomed Pharmacother. 2020;127:110180.","journal-title":"Biomed Pharmacother"},{"key":"1465_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/BF03011877","volume":"42","author":"S Kawana","year":"1995","unstructured":"Kawana S, Wachi J, Nakayama M, Namiki A. Comparison of haemodynamic changes induced by sevoflurane and halothane in paediatric patients. Can J Anaesth. 1995;42:603\u20137.","journal-title":"Can J Anaesth"},{"key":"1465_CR19","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1007\/s00784-019-02993-y","volume":"23","author":"M Tsukamoto","year":"2019","unstructured":"Tsukamoto M, Hitosugi T, Yokoyama T. Comparison of recovery in pediatric patients: a retrospective study. Clin Oral Investig. 2019;23:3653\u20136.","journal-title":"Clin Oral Investig"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-021-01465-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-021-01465-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-021-01465-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T04:54:22Z","timestamp":1634619262000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-021-01465-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1465"],"URL":"https:\/\/doi.org\/10.1186\/s12871-021-01465-9","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]},"assertion":[{"value":"15 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This single-center, prospective, parallel-groups clinical trial was approved by the Ethics Committee of Shanghai Children\u2019s Medical Center in China (SCMCIRB-K2018086) and registered at the Chinese Clinical Trial Registry website (ExternalRef removed, ChiCTR1900023715). Written informed consent was obtained from parents or legal guardians of each child before the trial began.Consent for publication.All parents or legal guardians of the patients enrolled in this study consented to their data being published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that there are no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"248"}}